课题基金 / 基金详情

Study on twnor growth inhibition by small interference RNAin nude mice

Study on twnor growth inhibition by small interference RNAin nude mice
小干扰RNA抑制裸鼠双胞胎生长的研究
批准号:
18591389
负责人:
OHNISHI Ken
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

OHNISHI Ken的其他基金

相似基金

相关文献

中文摘要
翻译
干扰抗凋亡和/或细胞增殖信号转导被认为是导致有效的放射治疗癌症。本研究利用培养的人癌细胞和移植的裸骨mica检测siRNA靶向DNA修复和信号转导中关键因子(NBS1和XIAP)在辐射后抗凋亡和/或细胞增殖中的作用,采用集落形成实验、Western blot、荧光免疫细胞化学和hoechst染色分析野生型p53或突变p53基因转染的人肺癌和舌癌细胞的辐射敏感性和凋亡情况。然后用转染了表达DNA盒的NBS1-siRNA的质粒转染癌细胞并进行辐射,检测转染的质粒对癌细胞的敏感性。与野生型p53细胞相比,靶向NBS1和XIAP的sirna在突变型p53细胞中单独增强了p53的辐射敏感性,甚至更为明显。目前,在表达质粒转染的NBS1-siRNA细胞的几个克隆中没有观察到增强的辐射敏感性。我们的研究结果表明,t NBS1-siRNA和XIAP siRNA可能有助于恶性肿瘤放射治疗的高疗效,从而增强p53独立的放射敏感性。此外,还需要进一步的实验来研究sirna在体内系统中的有效性。
英文摘要
Interference with anti-apoptosis and/or cellular proliferation signal transduction is regarded to result in effective radiation cancer therapy. This study examined the effectiveness of siRNA targeting key factors (NBS1 and XIAP) in DNA repair and signal transduction for anti-apoptosis and/or cellular proliferation after radiation using cultured human cancer cells and tumor-transplanted nude mica Radiation sensitivity and apoptosis were analyzed with colony formation assay, Western blot, fluorescent immuno-cytochemistry and hoechst staining using wild-type p53 or mutated p53 gene-transfected human lung and tongue cancer cells. Further the cancer cells were transfected with plasmids which were inserted with NBS1-siRNA expressing DNA cassette and radiation, sensitivity of the plasmid-transfected cells was examined. siRNAs targeting NBS1 and XIAP enhanced radiation sensitivity p53 independently and even more pronounced in mutated p53 cells compared with wild-type p53 cells. Enhanced radiation sensitivity was not observed in several clones from NBS1-siRNA expressing plasmid-transfected cells at this time. Our results suggest that t NBS1-siRNA and XIAP siRNA might contribute to high curative efficiency in radiation cancer therapy for malignant cancer leading to enhanced p53 independent radiation sensitivity. In addition, it was suggested that further experiments are required for study on the effectiveness of siRNAs in vivo system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
p53-independent apoptosis on human gingival cancer cells by heavy-ion beams
重离子束对人牙龈癌细胞的p53非依赖性细胞凋亡
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Yamakawa N., et. al.]
通讯作者: et. al.
Dynamics of DNA damage-recognizing proteins at heat-induced foci
热诱导病灶处 DNA 损伤识别蛋白的动态
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Takahashi A., et. al.]
通讯作者: et. al.
The role of polymerase β and HSPs on the thermo-tolerance
聚合酶β和热休克蛋白对耐热性的作用
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Yamakawa, N., et. al.]
通讯作者: et. al.
界面活性剤Tween80併用で増強される温熱による腫瘍増殖抑制
与表面活性剂 Tween80 组合增强热疗对肿瘤生长的抑制作用
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [大西 健, et. al.]
通讯作者: et. al.
共 86 条
    Screening of radio-sensitizing phytochemicals and examination on their structures
    Study on the radiation/heat/anti-cancer drag sensitivity enhanced by siRNA in mutated-p53 cancer cells
    • 批准号:
      20591502
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      OHNISHI Ken
    • 依托单位:
    Fundamental study on molecular chaperone cancer therapy
    • 批准号:
      12670899
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.7万
    • 财政年份:
      2000
    • 负责人:
      OHNISHI Ken
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: